<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">41284718</PMID><DateCompleted><Year>2025</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>11</Issue><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Trends and determinants of antenatal care use and quality in Bangladesh: Insights from demographic and health survey data.</ArticleTitle><Pagination><StartPage>e0337449</StartPage><MedlinePgn>e0337449</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0337449</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">High-quality antenatal care (ANC) reduces maternal and infant mortality and improves health outcomes, particularly in low-income countries. To assess the quality of ANC, three criteria are used: the number of visits, the timing of care initiation, and the inclusion of all recommended care components. The goal of this study was to identify and compare the factors associated with attending 4+ and 8&#x2009;+&#x2009;ANC visits as well as obtaining high-quality ANC.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data from the Bangladesh Demographic and Health Survey (BDHS) 2017--2018 and 2022 were used to evaluate the prevalence of ANC, and a binary logistic regression model was used. High quality ANC included the following components: blood pressure measurement, urine tests for detecting bacteriuria and proteinuria, blood tests for syphilis and anemia, iron supplementation, vitamin A administration, a child's health check before discharge, and health education.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In 2017--2018, 48% of women attended four or more visits, which decreased to 41% in 2022. ANC attendance for eight or more visits declined from 12% to 5%, and approximately 8% of women received no ANC in both periods. Higher levels of education among mothers and their spouses, urban residency and higher household wealth were positively correlated with ANC attendance and quality. Notably, essential components such as blood pressure monitoring and iron supplementation were more common among women with higher socioeconomic status, but their prevalence declined between 2017-2018 and 2022.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Continuous efforts must be made in Bangladesh to improve access to higher-quality ANC. It is vital to target women with lower levels of education who come from low-income families. More focus must be placed on enhancing women's education for long-term improvement.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2025 Barna et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barna</LastName><ForeName>Sutapa Dey</ForeName><Initials>SD</Initials><Identifier Source="ORCID">0000-0001-9554-4825</Identifier><AffiliationInfo><Affiliation>Statistics Discipline, Science Engineering and Technology School, Khulna University, Khulna, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quayyum</LastName><ForeName>Abdul</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Statistics Discipline, Science Engineering and Technology School, Khulna University, Khulna, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hossain</LastName><ForeName>Goffar</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Statistics Discipline, Science Engineering and Technology School, Khulna University, Khulna, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Islam</LastName><ForeName>Akhtarul</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Statistics Discipline, Science Engineering and Technology School, Khulna University, Khulna, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahman</LastName><ForeName>Fuad</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Statistics Discipline, Science Engineering and Technology School, Khulna University, Khulna, Bangladesh.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001459" MajorTopicYN="N" Type="Geographic">Bangladesh</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011295" MajorTopicYN="Y">Prenatal Care</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006306" MajorTopicYN="N">Health Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011787" MajorTopicYN="Y">Quality of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="Y">Patient Acceptance of Health Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>24</Day><Hour>18</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>24</Day><Hour>18</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>24</Day><Hour>13</Hour><Minute>41</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41284718</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0337449</ArticleId><ArticleId IdType="pii">PONE-D-25-15527</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">41280574</PMID><DateCompleted><Year>2025</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2249-4863</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>10</Issue><PubDate><Year>2025</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of family medicine and primary care</Title><ISOAbbreviation>J Family Med Prim Care</ISOAbbreviation></Journal><ArticleTitle>Intrapartum vitamin D levels a predictor of new-born anthropometry: An observational study in a teaching hospital of Eastern India.</ArticleTitle><Pagination><StartPage>4208</StartPage><EndPage>4215</EndPage><MedlinePgn>4208-4215</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/jfmpc.jfmpc_200_25</ELocationID><Abstract><AbstractText Label="UNLABELLED">Maternal vitamin D deficiency during pregnancy is a common issue and a significant global public health concern. Over the years, fetal growth and development have been studied, and it has been discovered that they are linked to vitamin D.</AbstractText><AbstractText Label="AIM AND OBJECTIVE" NlmCategory="UNASSIGNED">To estimate the vitamin D levels of mothers and neonates and determine an association between mothers' serum vitamin D status and neonate anthropometry.</AbstractText><AbstractText Label="METHODOLOGY" NlmCategory="UNASSIGNED">The research was performed between January 2020 and April 2021. A total of 97 participants-singleton (mother and neonate pair) at the time of delivery-were enrolled using convenient sampling. Five millilitres each of cord blood and maternal venous blood were taken at the time of delivery. Chemiluminescent immunoassay was used to analyse the vitamin D levels. One researcher measured the birth weight, length, head circumference, and chest circumference.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Mothers had 87.6% vitamin D deficiency. About 50.5% of newborns were vitamin D deficient. Multivariable logistic regression analysis was conducted to determine the vitamin D levels of the mother as a predictor of neonate anthropometry. It was found to be significant with neonate length and neonatal head circumference. Supplementation with vitamin D and calcium during pregnancy was also found to predict the birth weight of neonates.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Insufficient vitamin D was reported in 92.8% of mothers. Neonatal vitamin D insufficiency was found to be 94.8%. Neonatal vitamin D levels are substantially correlated with those of their mothers. Antenatal supplements of calcium along with vitamin D were seen to significantly improve birth weight and maternal vitamin D levels, while the extra supplementation of vitamin D during pregnancy significantly improved neonatal length and head circumference.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2025 Journal of Family Medicine and Primary Care.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saha</LastName><ForeName>Rubina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bibinagar, Telangana, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Pragya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Community and Family Medicine, All India Institute of Medical Sciences, Patna, Bihar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Shamshad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Community and Family Medicine, All India Institute of Medical Sciences, Patna, Bihar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahto</LastName><ForeName>Mala</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, All India Institute of Medical Sciences, Patna, Bihar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anant</LastName><ForeName>Monika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Patna, Bihar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padmanabhan</LastName><ForeName>Anantha A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Government Medical College, Thiruvananthapuram, Kerala, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranjan</LastName><ForeName>Alok</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Community and Family Medicine, All India Institute of Medical Sciences, Patna, Bihar, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>J Family Med Prim Care</MedlineTA><NlmUniqueID>101610082</NlmUniqueID><ISSNLinking>2249-4863</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anthropometry</Keyword><Keyword MajorTopicYN="N">Intrapartum</Keyword><Keyword MajorTopicYN="N">Mother</Keyword><Keyword MajorTopicYN="N">Neonate</Keyword><Keyword MajorTopicYN="N">Vitamin D</Keyword></KeywordList><CoiStatement>There are no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>24</Day><Hour>12</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>24</Day><Hour>12</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>24</Day><Hour>8</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41280574</ArticleId><ArticleId IdType="pmc">PMC12633990</ArticleId><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_200_25</ArticleId><ArticleId IdType="pii">JFMPC-14-4208</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>De-Regil LM, Palacios C, Lombardo LK, Pe&#xf1;a-Rosas JP. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2016:CD008873. doi: 10.1002/14651858. CD008873.pub3.</Citation><ArticleIdList><ArticleId IdType="pubmed">26765344</ArticleId></ArticleIdList></Reference><Reference><Citation>van Schoor NM, Lips P. Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab. 2011;25:671&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">21872807</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Gao JS, Yu SL, Qiu L, Zeng L, Wang DH. Correlation between neonatal vitamin D level and maternal vitamin D level. Zhongguo Dang dai er ke za zhi= Chinese J Contemp Pediatr. 2016;18:20&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390100</ArticleId><ArticleId IdType="pubmed">26781407</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Wang Y, Gao G, Guan X, Qin P, Liu C. High prevalence of vitamin d deficiency in pregnant women in South China.  [[Last accessed on 2021 May 31]];Int J Vitam Nutrition Res [Internet] 2019 90:273&#x2013;8. Available from: https://econtent.hogrefe.com/doi/abs/10.1024/0300-9831/a000592 .</Citation><ArticleIdList><ArticleId IdType="pubmed">31188079</ArticleId></ArticleIdList></Reference><Reference><Citation>Sogawa E, Kaji T, Nakayama S, Yoshida A, Yonetani N, Maeda K, et al. Seasonal variation of serum 25(OH) vitamin D levels in maternal and umbilical cord blood in Japanese women. J Med Invest. 2019;66:128&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">31064925</ArticleId></ArticleIdList></Reference><Reference><Citation>Velaphi SC, Izu A, Madhi SA, Pettifor JM. Maternal and neonatal vitamin D status at birth in black South Africans. S Afr Med J. 2019;109:807&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">31635580</ArticleId></ArticleIdList></Reference><Reference><Citation>Mensink-Bout SM, van Meel ER, de Jongste JC, Voortman T, Reiss IK, De Jong NW, et al. Maternal and neonatal 25-hydroxyvitamin D concentrations and school-age lung function, asthma and allergy. The Generation R Study. Clin Exp Allergy. 2019;49:900&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6850458</ArticleId><ArticleId IdType="pubmed">30866115</ArticleId></ArticleIdList></Reference><Reference><Citation>Lykkedegn S, Beck-Nielsen SS, Sorensen GL, Andersen LB, Fruekilde PB, Nielsen J, et al. Vitamin D supplementation, cord 25-hydroxyvitamin D and birth weight: Findings from the Odense Child Cohort. Clin Nutr. 2017;36:1621&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27817876</ArticleId></ArticleIdList></Reference><Reference><Citation>Wierzejska R, Jarosz M, Klemi&#x144;ska-Nowak M, Tomaszewska M, Sawicki W, Bachanek M, et al.  Maternal and cord blood vitamin D status and anthropometric measurements in term newborns at birth.  [[Last accessed on 2023 Mar 04]];Front Endocrinol [Internet] 2018 9:9. Available from: https://www.frontiersin.org/articles/10.3389/fendo.2018.00009 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5810294</ArticleId><ArticleId IdType="pubmed">29472892</ArticleId></ArticleIdList></Reference><Reference><Citation>Aly YF, El Koumi MA, Abd El Rahman RN. Impact of maternal vitamin D status during pregnancy on the prevalence of neonatal vitamin D deficiency. Pediatr Rep. 2013;5:e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3649745</ArticleId><ArticleId IdType="pubmed">23667735</ArticleId></ArticleIdList></Reference><Reference><Citation>Cadario F, Savastio S, Pozzi E, Capelli A, Dondi E, Gatto M, et al. Vitamin D status in cord blood and newborns: Ethnic differences. Ital J Pediatr. 2013;39:35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3685533</ArticleId><ArticleId IdType="pubmed">23735116</ArticleId></ArticleIdList></Reference><Reference><Citation>Alp H, Tekg&#xfc;nd&#xfc;z K&#x15e;, Akkar MK. Maternal and cord blood vitamin D status in high-altitude pregnancy. J Matern Fetal Neonatal Med. 2016;29:571&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">25690026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponsonby AL, Lucas RM, Lewis S, Halliday J. Vitamin D status during pregnancy and aspects of offspring health. Nutrients. 2010;2:389&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3257641</ArticleId><ArticleId IdType="pubmed">22254029</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorne-Lyman A, Fawzi WW. Vitamin D during pregnancy and maternal, neonatal and infant health outcomes: A systematic review and meta-analysis. Paediatr Perinat Epidemiol. 2012;26(Suppl 1):75&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3843348</ArticleId><ArticleId IdType="pubmed">22742603</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O&#x2019;Beirne M, Rabi DM. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: Systematic review and meta-analysis of observational studies. BMJ. 2013;346:f1169.</Citation><ArticleIdList><ArticleId IdType="pubmed">23533188</ArticleId></ArticleIdList></Reference><Reference><Citation>Gernand AD, Schulze KJ, Stewart CP, West KP, Jr, Christian P. Micronutrient deficiencies in pregnancy worldwide: Health effects and prevention. Nat Rev Endocrinol. 2016;12:274&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4927329</ArticleId><ArticleId IdType="pubmed">27032981</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossein-nezhad A, Holick MF. Vitamin D for health: A global perspective. Mayo Clin Proc. 2013;88:720&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3761874</ArticleId><ArticleId IdType="pubmed">23790560</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain N, Kanani FH, Ramzan S, Kausar R, Ayaz S, Khanani R, et al. Obstetric and neonatal outcomes of maternal vitamin D supplementation: Results of an open-label, randomized controlled trial of antenatal vitamin D supplementation in Pakistani women. J Clin Endocrinol Metab. 2014;99:2448&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">24646102</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon RJ, Davies JH, Cooper C, Harvey NC. Vitamin D, and maternal and child health. Calcif Tissue Int. 2020;106:30&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7019685</ArticleId><ArticleId IdType="pubmed">31089772</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee RW, Chng AL, Tan KH IPRAMHO International Study Group. Clinical practice of vitamin D screening and supplementation in pregnancy in Asia-pacific countries: A cross-sectional study.  [[Last accessed on 2025 Apr 29]];Heliyon. 2023 9:e21186. Available from: https://www.sciencedirect.com/science/article/pii/S2405844023083949 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10684368</ArticleId><ArticleId IdType="pubmed">38034721</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma N, Nath C, Mohammad J. Vitamin D status in pregnant women visiting a tertiary care center of North Eastern India. J Family Med Prim Care. 2019;8:356&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6436274</ArticleId><ArticleId IdType="pubmed">30984638</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra SC. National Guidelines for Calcium Supplementation During Pregnancy and Lactation. In Nirman Bhawan New Delhi-110011: Maternal Health Division Ministry of Health &amp; Family Welfare Government of India. 2014.  Available from: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/ 
https://nhm.gov.in/images/pdf/programmes/maternal-health/guidelines/National_Guidelines_for_Calcium_Supplementation_During_Pregnancy_and_Lactation.pdf. 
</Citation></Reference><Reference><Citation>Antenatal iron supplementation [Internet] 2018.  [[Last accessed on 2023 Mar 03]].  Available from: https://www.who.int/data/nutrition/nlis/info/antenatal-iron-supplementation .</Citation></Reference><Reference><Citation>Sachdeva S. Fitzpatrick skin typing: Applications in dermatology. Indian J Dermatol Venereol Leprol. 2009;75:93&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19172048</ArticleId></ArticleIdList></Reference><Reference><Citation>Idris R. INTERGROWTH-21st Module 1 Assessing newborn size by anthropometry [Internet. University of Oxford. 2016.  [[cited 2021 Jun 3]].  Available from: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/ 
https://www.gfmer.ch/omphi/intergrowth-course/pdf/Intergrowth-21st-Module1-Assessing-newborn-size%20by-anthropometry-2016.pdf. 
</Citation></Reference><Reference><Citation>Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">17634462</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick MF. MrOs Is D-ficient. J Clin Endocrinol Metab. 2009;94:1092&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">19349475</ArticleId></ArticleIdList></Reference><Reference><Citation>Godel JC. Canadian Paediatric Society, First Nations, Inuit and M&#xe9;tis Health Committee, Vitamin D supplementation: Recommendations for Canadian mothers and infants. Paediatr Child Health. 2007;12:583&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2528771</ArticleId><ArticleId IdType="pubmed">19030432</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S, Kumar A, Prasad S, Sharma S. Current scenario of vitamin D status during pregnancy in North Indian population. J Obstet Gynaecol India. 2016;66:93&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4818828</ArticleId><ArticleId IdType="pubmed">27046962</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal BP, Kumar A, Ansari MA, Saran J. To evaluate the effect of maternal Vitamin D deficiency on increased risk for hyperbilirubinemia in term newborns: An observational study.  [[Last accessed on 2021 Jun 01]];Int J Health Clin Res. 2021 4:249&#x2013;52. Available from: https://www.ijhcr.com/index.php/ijhcr/article/view/822 .</Citation></Reference><Reference><Citation>Sachan A, Gupta R, Das V, Agarwal A, Awasthi PK, Bhatia V. High prevalence of vitamin D deficiency among pregnant women and their newborns in Northern India. Am J Clin Nutr. 2005;81:1060&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">15883429</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora S, Goel P, Chawla D, Huria A, Arya A. Vitamin D status in mothers and their newborns and its association with pregnancy outcomes: Experience from a tertiary care center in Northern India. J Obstet Gynaecol India. 2018;68:389&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6133794</ArticleId><ArticleId IdType="pubmed">30224844</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal R, Virmani D, Jaipal ML, Gupta S, Gupta N, Sankar MJ, et al. Vitamin D status of low birth weight infants in Delhi: A comparative study. J Trop Pediatr. 2012;58:446&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">22529320</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariyawatkul K, Lersbuasin P. Prevalence of vitamin D deficiency in cord blood of newborns and the association with maternal vitamin D status. Eur J Pediatr. 2018;177:1541&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">30027298</ArticleId></ArticleIdList></Reference><Reference><Citation>Maghbooli Z, Hossein-Nezhad A, Shafaei AR, Karimi F, Madani FS, Larijani B. Vitamin D status in mothers and their newborns in Iran. BMC Pregnancy Childbirth. 2007;7:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1808477</ArticleId><ArticleId IdType="pubmed">17295904</ArticleId></ArticleIdList></Reference><Reference><Citation>Beral V, Evans S, Shaw H, Milton G. Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol. 1983;109:165&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">6871096</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock MA. Assessment of sun sensitivity by questionnaire: Validity of items and formulation of a prediction rule. J Clin Epidemiol. 1992;45:547&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">1588360</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalid AT, Moore CG, Hall C, Olabopo F, Rozario NL, Holick MF, et al. Utility of sun-reactive skin typing and melanin index for discerning vitamin D deficiency. Pediatr Res. 2017;82:444&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5570640</ArticleId><ArticleId IdType="pubmed">28467404</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard A, Rohrmann S, Quack L&#xf6;tscher KC. Prevalence of vitamin D deficiency and its associations with skin color in pregnant women in the first trimester in a sample from Switzerland.  [[Last accessed on 2020 Nov 27]];Nutrients [Internet. 2017 9:260. Available from: https://www.mdpi.com/2072-6643/9/3/260 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5372923</ArticleId><ArticleId IdType="pubmed">28287422</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez A, Garc&#xed;a-Esteban R, Basterretxea M, Lertxundi A, Rodr&#xed;guez-Bernal C, I&#xf1;iguez C, et al. Associations of maternal circulating 25-hydroxyvitamin D3 concentration with pregnancy and birth outcomes. BJOG. 2015;122:1695&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">25208685</ArticleId></ArticleIdList></Reference><Reference><Citation>Mojibian M, Soheilykhah S, Fallah Zadeh MA, Jannati Moghadam M. The effects of vitamin D supplementation on maternal and neonatal outcome: A randomized clinical trial. Iran J Reprod Med. 2015;13:687&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4695683</ArticleId><ArticleId IdType="pubmed">26730243</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalessi N, Kalani M, Araghi M, Farahani Z. The relationship between maternal vitamin D deficiency and low birth weight neonates. J Family Reprod Health. 2015;9:113&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4662754</ArticleId><ArticleId IdType="pubmed">26622309</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SS, Ling KH, Tusimin M, Subramaniam R, Rahim KF, Loh SP. Interplay between maternal and neonatal vitamin D deficiency and vitamin-D-Related gene polymorphism with neonatal birth anthropometry. Nutrients. 2022;14:564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8839863</ArticleId><ArticleId IdType="pubmed">35276923</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-L&#xf3;pez FR, Pasupuleti V, Mezones-Holguin E, Benites-Zapata VA, Thota P, Deshpande A, et al. Effect of vitamin D supplementation during pregnancy on maternal and neonatal outcomes: A systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2015;103:1278&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">25813278</ArticleId></ArticleIdList></Reference><Reference><Citation>Karras SN, Dursun E, Alayl&#x131;o&#x11f;lu M, Gezen-Ak D, Pilz S, Annweiler C, et al. Maternal and neonatal vitamin D binding protein polymorphisms and 25-Hydroxyvitamin D cutoffs as determinants of neonatal birth anthropometry. Nutrients. 2022;14:3799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9504771</ArticleId><ArticleId IdType="pubmed">36145176</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou C, Talbot K, Ohuma E, Sarris I, Villar J, Conde-Agudelo A, et al. Systematic review of methodology used in ultrasound studies aimed at creating charts of fetal size. BJOG. 2012;119:1425&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">22882780</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooke OG, Brown IR, Bone CD, Carter ND, Cleeve HJ, Maxwell JD, et al. Vitamin D supplements in pregnant Asian women: Effects on calcium status and fetal growth. Br Med J. 1980;280:751&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1600591</ArticleId><ArticleId IdType="pubmed">6989438</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahon P, Harvey N, Crozier S, Inskip H, Robinson S, Arden N, et al. Low maternal vitamin D status and fetal bone development: Cohort study. J Bone Miner Res. 2010;25:14&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4768344</ArticleId><ArticleId IdType="pubmed">19580464</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis EC, Hinkle SN, Song Y, Rawal S, Donnelly SR, Zhu Y, et al. Longitudinal maternal vitamin D status during pregnancy is associated with neonatal anthropometric measures. Nutrients. 2018;10:1631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6265933</ArticleId><ArticleId IdType="pubmed">30400155</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">41277701</PMID><DateRevised><Year>2025</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1753-4887</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Nov</Month><Day>24</Day></PubDate></JournalIssue><Title>Nutrition reviews</Title><ISOAbbreviation>Nutr Rev</ISOAbbreviation></Journal><ArticleTitle>Comparative Analysis of Treatment With Folate Forms in Clinical Practice.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">nuaf216</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/nutrit/nuaf216</ELocationID><Abstract><AbstractText>Folate compounds are crucial for DNA and RNA synthesis, homocysteine regulation, and epigenetic methylation. However, significant differences exist between 5-methyltetrahydrofolate (5-MTHF) and folinic acid (CHO-THF) -and synthetic folic acid (sFA). Understanding their absorption, bioavailability, and clinical effects is essential, especially for women planning pregnancy, pregnant women, and patients with MTHFR or DHFR polymorphisms, autism spectrum disorders, or other folate-related conditions. A comparative analysis of clinical and biochemical studies was conducted to evaluate the efficacy, safety, and optimal dosing of these folate forms. 5-MTHF and CHO-THF demonstrated key advantages over sFA, including avoidance of unmetabolized folic acid accumulation, reduced risk of masking vitamin B12 deficiency, and improved metabolic support in individuals with genetic variants or folate receptor dysfunction. Both forms also show enhanced activity in high-dose therapies for patients with autoantibodies to folate receptors or transport defects. 5-MTHF efficiently crosses the blood-brain barrier, supports fetal and neonatal brain development, and has shown potential in improving cognitive function and depressive symptoms. CHO-THF exhibits promise in managing autism spectrum disorders by modulating neurotransmission and neurometabolic pathways. Despite these advantages, sFA remains the only folate form with proven efficacy in large randomized clinical trials for preventing neural tube defects (NTDs) and continues to play a key role in public health strategies. Use of sFA at doses above 1000 &#xb5;g/day requires monitoring to avoid masking B12 deficiency. For personalized or high-risk cases, 5-MTHF and CHO-THF should be the preferred options, ideally combined with vitamin B12 supplementation.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site&#x2014;for further information please contact journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Skavinska</LastName><ForeName>Oleksandra</ForeName><Initials>O</Initials><Identifier Source="ORCID">0009-0003-7506-8384</Identifier><AffiliationInfo><Affiliation>Expert-Analytical Center of Molecular Genetics of the Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossokha</LastName><ForeName>Zoia</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Expert-Analytical Center of Molecular Genetics of the Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stefanyshyn</LastName><ForeName>Volodymyr</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Neuroimmunology Clinic "Vivere," Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hrebeniuk</LastName><ForeName>Olena</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Neuroimmunology Clinic "Vivere," Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fishchuk</LastName><ForeName>Liliia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9999-7389</Identifier><AffiliationInfo><Affiliation>Expert-Analytical Center of Molecular Genetics of the Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quadros</LastName><ForeName>Edward V</ForeName><Initials>EV</Initials><AffiliationInfo><Affiliation>SUNY Downstate Medical Center Brooklyn, Brooklyn, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gorovenko</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Shupyk National Healthcare University of Ukraine, Department of Medical and Laboratory Genetics, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nutr Rev</MedlineTA><NlmUniqueID>0376405</NlmUniqueID><ISSNLinking>0029-6643</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">5-methyltetrahydrofolate</Keyword><Keyword MajorTopicYN="N">autism spectrum disorders</Keyword><Keyword MajorTopicYN="N">folates</Keyword><Keyword MajorTopicYN="N">folinic acid</Keyword><Keyword MajorTopicYN="N">neuropsychiatric development</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword><Keyword MajorTopicYN="N">synthetic folic acid</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>24</Day><Hour>12</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>24</Day><Hour>12</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>54</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41277701</ArticleId><ArticleId IdType="doi">10.1093/nutrit/nuaf216</ArticleId><ArticleId IdType="pii">8341054</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">41272611</PMID><DateRevised><Year>2025</Year><Month>11</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-2407</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Nov</Month><Day>21</Day></PubDate></JournalIssue><Title>BMC cancer</Title><ISOAbbreviation>BMC Cancer</ISOAbbreviation></Journal><ArticleTitle>Prenatal exposure to medication and risk of childhood cancer - a systematic review and meta-analysis.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12885-025-15316-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The use of medication during pregnancy carries a potential health risk, including childhood cancer, for the unborn child. However, most drugs examined in previous observational studies have shown inconsistent results with the risk of childhood cancer, and these findings have not been consolidated in drug-specific meta-analyses.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a systematic search in the databases PubMed and Web of Science for studies on medication use during pregnancy and childhood cancer risk. Studies with exposure to diethylstilbestrol as a known teratogen were excluded. Meta-analyses were conducted if&#x2009;&#x2265;&#x2009;3 studies on the same research question were available to calculate pooled estimates for random effects models with 95% confidence intervals (CI). The I<sup>2</sup> statistic was calculated to quantify between-study heterogeneity. Statistical significance of I<sup>2</sup> was analyzed using Q statistic (P value for heterogeneity (P)). Study quality was assessed with a scoring tool adapted from the Newcastle-Ottawa Scale and ROBINS-E/I.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 2,366 identified studies, 80 were included in the systematic review. Of these, 68 studies with a total of 14,396,922 participants were included in meta-analyses, covering 13 medication types and 11 childhood cancer sites across 70 analyses. From 54 site-specific analyses, we observed four risk reductions and eleven increases in risk. We found an increased risk for prenatal exposure to any kind of antibiotics and acute lymphoblastic leukemia (ALL; estimate (ES)&#x2009;=&#x2009;1.14 (95%CI 1.03; 1.25), I<sup>2</sup>&#x2009;=&#x2009;19.1%, P&#x2009;=&#x2009;0.26). For specific antibiotics, nitrosatable antibiotics were associated with an increased risk of childhood cancer overall (ES&#x2009;=&#x2009;1.32 (1.13; 1.55), I<sup>2</sup>&#x2009;=&#x2009;0.0%, P&#x2009;=&#x2009;0.98). Maternal intake of vitamin and mineral supplements was associated with a reduced risk of acute leukemia (AL) (ES&#x2009;=&#x2009;0.72 (0.54; 0.96), I<sup>2=</sup>46.3%, P&#x2009;=&#x2009;0.16), ALL (ES&#x2009;=&#x2009;0.81 (0.67; 0.99), I<sup>2</sup>&#x2009;=&#x2009;66.6%, P&#x2009;=&#x2009;0.001) and tumors of the central nervous system (CNS; ES&#x2009;=&#x2009;0.77 (0.62; 0.96), I<sup>2</sup>&#x2009;=&#x2009;67.2%, P&#x2009;=&#x2009;0.002).</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Our results suggest that the use of antibiotics during pregnancy was associated with an increased childhood cancer risk, although this association is likely influenced by the underlying maternal infections that required treatment. This highlights the importance of considering maternal health factors when interpreting medication-related associations. Supplementation of vitamins and minerals during pregnancy might decrease the risk of AL, ALL and CNS tumors in children.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>L&#xfc;btow</LastName><ForeName>Alicia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department Epidemiological Methods and Etiological Research, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marron</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department Epidemiological Methods and Etiological Research, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagrani</LastName><ForeName>Rajini</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department Epidemiological Methods and Etiological Research, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulanje</LastName><ForeName>Loviisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department Epidemiological Methods and Etiological Research, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Human and Health Sciences, University of Bremen, Bremen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahrens</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department Epidemiological Methods and Etiological Research, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brackmann</LastName><ForeName>Lara Kim</ForeName><Initials>LK</Initials><AffiliationInfo><Affiliation>Department Epidemiological Methods and Etiological Research, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany. brackmann@leibniz-bips.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>11</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Cancer</MedlineTA><NlmUniqueID>100967800</NlmUniqueID><ISSNLinking>1471-2407</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antibiotics</Keyword><Keyword MajorTopicYN="N">Leukemia</Keyword><Keyword MajorTopicYN="N">Malignancy</Keyword><Keyword MajorTopicYN="N">Neoplasms</Keyword><Keyword MajorTopicYN="N">Pharmaceutical preparations</Keyword><Keyword MajorTopicYN="N">Pregnancy</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>22</Day><Hour>0</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41272611</ArticleId><ArticleId IdType="doi">10.1186/s12885-025-15316-0</ArticleId><ArticleId IdType="pii">10.1186/s12885-025-15316-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cancer today: International Regency for Research on Cancer. 2022. Available from: https://gco.iarc.fr/today/en/dataviz/pie?mode=cancer%3C;26;group_populations=1%3C;26;age_end=3%3C;26;populations=100_112_191_196_203_208_233_246_250_276_300_348_352_372_380_40_428_440_442_470_498_499_528_56_578_616_620_642_643_688_70_703_705_724_752_756_8_804_807_826. As of: 20.06.2024).</Citation></Reference><Reference><Citation>Spix C, Erdmann F, Grabow D, Ronckers C. Krebs im Kindes- und Jugendalter in Deutschland &#x2013; ein &#xdc;berblick. J Health Monit. 2023;2:82&#x2013;97.</Citation></Reference><Reference><Citation>Erdmann F KP, Grabow D et al. German Childhood Cancer Registry - Annual Report 2019 (1980&#x2013;2018). Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) at the University Medical Center of the Johannes Gutenberg University Mainz, 2020. https://www.kinderkrebsregister.de/fileadmin/kliniken/dkkr/pdf/jb/jb2019/Buch_DKKR_Jahresbericht_2019_komplett.pdf</Citation></Reference><Reference><Citation>Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992&#x2013;2004). Cancer. 2008;112(2):416&#x2013;32.</Citation></Reference><Reference><Citation>Schmidt JA, Hornhardt S, Erdmann F, S&#xe1;nchez-Garc&#xed;a I, Fischer U, Sch&#xfc;z J, et al. Risk factors for childhood leukemia: radiation and beyond. Front Public Health. 2021;9:805757.</Citation></Reference><Reference><Citation>Buka I, Koranteng S, Osornio Vargas AR. Trends in childhood cancer incidence: review of environmental linkages. Pediatr Clin North Am. 2007;54(1):177&#x2013;203 x.</Citation></Reference><Reference><Citation>Greaves M. A causal mechanism for childhood acute lymphoblastic leukaemia. Nat Rev Cancer. 2018;18(8):471&#x2013;84.</Citation></Reference><Reference><Citation>Eden T. Aetiology of childhood leukaemia. Cancer Treat Rev. 2010;36(4):286&#x2013;97.</Citation></Reference><Reference><Citation>Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer. 2006;6(3):193&#x2013;203.</Citation></Reference><Reference><Citation>Niemeyer C, Eggert A. P&#xe4;diatrische H&#xe4;matologie und Onkologie. Berlin Heidelberg: Springer; 2017.</Citation></Reference><Reference><Citation>Bloom M, Maciaszek JL, Clark ME, Pui CH, Nichols KE. Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia. Expert Rev Hematol. 2020;13(1):55&#x2013;70.</Citation></Reference><Reference><Citation>Spector LG, Pankratz N, Marcotte EL. Genetic and nongenetic risk factors for childhood cancer. Pediatr Clin North Am. 2015;62(1):11&#x2013;25.</Citation></Reference><Reference><Citation>Bunin GR. Nongenetic causes of childhood cancers: evidence from international variation, time trends, and risk factor studies. Toxicol Appl Pharmacol. 2004;199(2):91&#x2013;103.</Citation></Reference><Reference><Citation>Chang JS, Tsai C-R, Tsai Y-W, Wiemels JL. Medically diagnosed infections and risk of childhood leukaemia: a population-based case&#x2013;control study. Int J Epidemiol. 2012;41(4):1050&#x2013;9.</Citation></Reference><Reference><Citation>He JR, Yu Y, Fang F, Gissler M, Magnus P, L&#xe1;szl&#xf3; KD, et al. Evaluation of maternal infection during pregnancy and childhood leukemia among offspring in Denmark. JAMA Netw Open. 2023;6(2):e230133.</Citation></Reference><Reference><Citation>Kwan ML, Metayer C, Crouse V, Buffler PA. Maternal illness and drug/medication use during the period surrounding pregnancy and risk of childhood leukemia among offspring. Am J Epidemiol. 2007;165(1):27&#x2013;35.</Citation></Reference><Reference><Citation>King JC. Physiology of pregnancy and nutrient metabolism. Am J Clin Nutr. 2000;71(5 Suppl):1218s-s1225.</Citation></Reference><Reference><Citation>Carlin A, Alfirevic Z. Physiological changes of pregnancy and monitoring. Best Pract Res Clin Obstet Gynaecol. 2008;22(5):801&#x2013;23.</Citation></Reference><Reference><Citation>Jamieson DJ, Theiler RN, Rasmussen SA. Emerging infections and pregnancy. Emerg Infect Dis. 2006;12(11):1638&#x2013;43.</Citation></Reference><Reference><Citation>Hjorth S, Hemmingsen CH, B&#xe9;n&#xe9;vent J, Broe A, Pottegaard A, M&#xf8;rch LS, et al. Maternal medication use and childhood cancer in offspring-systematic review and considerations for researchers. Am J Epidemiol. 2021;190(11):2487&#x2013;99.</Citation></Reference><Reference><Citation>Mansour O, Russo RG, Straub L, Bateman BT, Gray KJ, Huybrechts KF, et al. Prescription medication use during pregnancy in the United States from 2011 to 2020: trends and safety evidence. Am J Obstet Gynecol.</Citation></Reference><Reference><Citation>Fortinguerra F, Belleudi V, Poggi FR, Bortolus R, Puccini A, Solfrini V, et al. Medication prescriptions before, during and after pregnancy in Italy: a population-based study. Ann Ist Super Sanita. 2021;57(3):249&#x2013;58.</Citation></Reference><Reference><Citation>Larcin L, Lona M, Karakaya G, Van Espen A, Damase-Michel C, Kirakoya-Samadoulougou F. Using administrative healthcare database records to study trends in prescribed medication dispensed during pregnancy in Belgium from 2003 to 2017. Pharmacoepidemiol Drug Saf. 2021;30(9):1224&#x2013;32.</Citation></Reference><Reference><Citation>B&#xe9;rard A, Abbas-Chorfa F, Kassai B, Vial T, Nguyen KA, Sheehy O, et al. The French pregnancy cohort: medication use during pregnancy in the French population. PLoS One. 2019;14(7):e0219095.</Citation></Reference><Reference><Citation>Daw JR, Hanley GE, Greyson DL, Morgan SG. Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemiol Drug Saf. 2011;20(9):895&#x2013;902.</Citation></Reference><Reference><Citation>Haas DM, Marsh DJ, Dang DT, Parker CB, Wing DA, Simhan HN, et al. Prescription and other medication use in pregnancy. Obstet Gynecol. 2018;131(5):789&#x2013;98.</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.</Citation></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008&#x2013;12.</Citation></Reference><Reference><Citation>Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971;284(15):878&#x2013;81.</Citation></Reference><Reference><Citation>Cummings P. The relative merits of risk ratios and odds ratios. Arch Pediatr Adolesc Med. 2009;163(5):438&#x2013;45.</Citation></Reference><Reference><Citation>Gold E, Gordis L, Tonascia J, Szklo M. Increased risk of brain tumors in children exposed to barbiturates. J Natl Cancer Inst. 1978;61(4):1031&#x2013;4.</Citation></Reference><Reference><Citation>van Steensel-Moll HA, Valkenburg HA, Vandenbroucke JP, van Zanen GE. Are maternal fertility problems related to childhood leukaemia? Int J Epidemiol. 1985;14(4):555&#x2013;9.</Citation></Reference><Reference><Citation>McKinney PA, Cartwright RA, Stiller CA, Hopton PA, Mann JR, Birch JM, et al. Inter-regional epidemiological study of childhood cancer (IRESCC): childhood cancer and the consumption of debendox and related drugs in pregnancy. Br J Cancer. 1985;52(6):923&#x2013;9.</Citation></Reference><Reference><Citation>Kramer S, Ward E, Meadows AT, Malone KE. Medical and drug risk factors associated with neuroblastoma: a case-control study. J Natl Cancer Inst. 1987;78(5):797&#x2013;804.</Citation></Reference><Reference><Citation>Buckley JD, Sather H, Ruccione K, Rogers PC, Haas JE, Henderson BE, et al. A case-control study of risk factors for hepatoblastoma. A report from the Childrens Cancer Study Group. Cancer. 1989;64(5):1169&#x2013;76.</Citation></Reference><Reference><Citation>Robison LL, Buckley JD, Daigle AE, Wells R, Benjamin D, Arthur DC, et al. Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the Childrens Cancer Study Group). Cancer. 1989;63(10):1904&#x2013;11.</Citation></Reference><Reference><Citation>Goldhaber MK, Selby JV, Hiatt RA, Quesenberry CP. Exposure to barbiturates in utero and during childhood risk of intracranial and spinal cord tumors. Cancer Res. 1990;50(15):4600&#x2013;3.</Citation></Reference><Reference><Citation>Kuijten RR, Bunin GR, Nass CC, Meadows AT. Gestational and familial risk factors for childhood astrocytoma: results of a case-control study. Cancer Res. 1990;50(9):2608&#x2013;12.</Citation></Reference><Reference><Citation>Schwartzbaum JA. Influence of the mother&#x2019;s prenatal drug consumption on risk of neuroblastoma in the child. Am J Epidemiol. 1992;135(12):1358&#x2013;67.</Citation></Reference><Reference><Citation>Cordier S, Iglesias MJ, Le Goaster C, Guyot MM, Mandereau L, Hemon D. Incidence and risk factors for childhood brain tumors in the Ile de France. Int J Cancer. 1994;59(6):776&#x2013;82.</Citation></Reference><Reference><Citation>McCredie M, Maisonneuve P, Boyle P. Antenatal risk factors for malignant brain tumours in New South Wales children. Int J Cancer. 1994;56(1):6&#x2013;10.</Citation></Reference><Reference><Citation>Shu XO, Nesbit ME, Buckley JD, Krailo MD, Robison LL. An exploratory analysis of risk-factors for childhood malignant germ-cell tumors - report from the Childrens Cancer Group (Canada, United States). Cancer Causes Control. 1995;6(3):187&#x2013;98.</Citation></Reference><Reference><Citation>Michalek AM, Buck GM, Nasca PC, Freedman AN, Baptiste MS, Mahoney MC. Gravid health status, medication use, and risk of neuroblastoma. Am J Epidemiol. 1996;143(10):996&#x2013;1001.</Citation></Reference><Reference><Citation>Preston-Martin S, Pogoda JM, Mueller BA, Lubin F, Holly EA, Filippini G, et al. Prenatal vitamin supplementation and risk of childhood brain tumors. Int J Cancer Suppl. 1998;11:17&#x2013;22.</Citation></Reference><Reference><Citation>Thapa PB, Whitlock JA, Brockman Worrell KG, Gideon P, Mitchel EF Jr., Roberson P, et al. Prenatal exposure to metronidazole and risk of childhood cancer: a retrospective cohort study of children younger than 5 years. Cancer. 1998;83(7):1461&#x2013;8.</Citation></Reference><Reference><Citation>McKinney PA, Juszczak E, Findlay E, Smith K, Thomson CS. Pre- and perinatal risk factors for childhood leukaemia and other malignancies: a Scottish case control study. Br J Cancer. 1999;80(11):1844&#x2013;51.</Citation></Reference><Reference><Citation>Sch&#xfc;z J, Kaletsch U, Meinert R, Kaatsch P, Spix C, Michaelis J. Risk factors for neuroblastoma at different stages of disease. Results from a population-based case-control study in Germany. J Clin Epidemiol. 2001;54(7):702&#x2013;9.</Citation></Reference><Reference><Citation>Thompson JR, Gerald PF, Willoughby ML, Armstrong BK. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet. 2001;358(9297):1935&#x2013;40.</Citation></Reference><Reference><Citation>Olshan AF, Smith JC, Bondy ML, Neglia JP, Pollock BH. Maternal vitamin use and reduced risk of neuroblastoma. Epidemiology. 2002;13(5):575&#x2013;80.</Citation></Reference><Reference><Citation>Shu XO, Han D, Severson RK, Chen Z, Neglia JP, Reaman GH, et al. Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States). Cancer Causes Control. 2002;13(1):15&#x2013;25.</Citation></Reference><Reference><Citation>Wen W, Shu XO, Potter JD, Severson RK, Buckley JD, Reaman GH, et al. Parental medication use and risk of childhood acute lymphoblastic leukemia. Cancer. 2002;95(8):1786&#x2013;94.</Citation></Reference><Reference><Citation>Cook MN, Olshan AF, Guess HA, Savitz DA, Poole C, Blatt J, et al. Maternal medication use and neuroblastoma in offspring. Am J Epidemiol. 2004;159(8):721&#x2013;31.</Citation></Reference><Reference><Citation>Shaw AK, Infante-Rivard C, Morrison HI. Use of medication during pregnancy and risk of childhood leukemia (Canada). Cancer Causes Control. 2004;15(9):931&#x2013;7.</Citation></Reference><Reference><Citation>Bunin GR, Gallagher PR, Rorke-Adams LB, Robison LL, Cnaan A. Maternal supplement, micronutrient, and cured meat intake during pregnancy and risk of medulloblastoma during childhood: a children&#x2019;s oncology group study. Cancer Epidemiol Biomarkers Prev. 2006;15(9):1660&#x2013;7.</Citation></Reference><Reference><Citation>Pombo-de-Oliveira MS, Koifman S. Infant acute leukemia and maternal exposures during pregnancy. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2336&#x2013;41.</Citation></Reference><Reference><Citation>Shankar S, Davies S, Giller R, Krailo M, Davis M, Gardner K, et al. In utero exposure to female hormones and germ cell tumors in children. Cancer. 2006;106(5):1169&#x2013;77.</Citation></Reference><Reference><Citation>Dockerty JD, Herbison P, Skegg DC, Elwood M. Vitamin and mineral supplements in pregnancy and the risk of childhood acute lymphoblastic leukaemia: a case-control study. BMC Public Health. 2007;7:136.</Citation></Reference><Reference><Citation>Sch&#xfc;z J, Weihkopf T, Kaatsch P. Medication use during pregnancy and the risk of childhood cancer in the offspring. Eur J Pediatr. 2007;166(5):433&#x2013;41.</Citation></Reference><Reference><Citation>Benhammou V, Warszawski J, Bellec S, Doz F, Andr&#xe9; N, Lacour B, et al. Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors. AIDS. 2008;22(16):2165&#x2013;77.</Citation></Reference><Reference><Citation>Johnson KJ, Poynter JN, Ross JA, Robison LL, Shu XO. Pediatric germ cell tumors and maternal vitamin supplementation: a Children&#x2019;s Oncology Group study. Cancer Epidemiol Biomarkers Prev. 2009;18(10):2661&#x2013;4.</Citation></Reference><Reference><Citation>Kaatsch P, Scheidemann-Wesp U, Sch&#xfc;z J. Maternal use of antibiotics and cancer in the offspring: results of a case-control study in Germany. Cancer Causes Control. 2010;21(8):1335&#x2013;45.</Citation></Reference><Reference><Citation>Linabery AM, Puumala SE, Hilden JM, Davies SM, Heerema NA, Roesler MA, et al. Maternal vitamin and iron supplementation and risk of infant leukaemia: a report from the Children&#x2019;s Oncology Group. Br J Cancer. 2010;103(11):1724&#x2013;8.</Citation></Reference><Reference><Citation>Milne E, Royle JA, Miller M, Bower C, de Klerk NH, Bailey HD, et al. Maternal folate and other vitamin supplementation during pregnancy and risk of acute lymphoblastic leukemia in the offspring. Int J Cancer. 2010;126(11):2690&#x2013;9.</Citation></Reference><Reference><Citation>Ortega-Garc&#xed;a JA, Ferr&#xed;s-Tortajada J, Claudio L, Soldin OP, Sanchez-Sauco MF, Fuster-Soler JL, et al. Case control study of periconceptional folic acid intake and nervous system tumors in children. Childs Nerv Syst. 2010;26(12):1727&#x2013;33.</Citation></Reference><Reference><Citation>St&#xe5;lberg K, Haglund B, Str&#xf6;mberg B, Kieler H. Prenatal exposure to medicines and the risk of childhood brain tumor. Cancer Epidemiol. 2010;34(4):400&#x2013;4.</Citation></Reference><Reference><Citation>Amigou A, Rudant J, Orsi L, Goujon-Bellec S, Leverger G, Baruchel A, et al. Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE). Cancer Causes Control. 2012;23(8):1265&#x2013;77.</Citation></Reference><Reference><Citation>Milne E, Greenop KR, Bower C, Miller M, van Bockxmeer FM, Scott RJ, et al. Maternal use of folic acid and other supplements and risk of childhood brain tumors. Cancer Epidemiol Biomarkers Prev. 2012;21(11):1933&#x2013;41.</Citation></Reference><Reference><Citation>Ajrouche R, Rudant J, Orsi L, Petit A, Baruchel A, Nelken B, et al. Maternal reproductive history, fertility treatments and folic acid supplementation in the risk of childhood acute leukemia: the ESTELLE study. Cancer Causes Control. 2014;25(10):1283&#x2013;93.</Citation></Reference><Reference><Citation>Bonaventure A, Simpson J, Ansell P, Roman E, Lightfoot T. Prescription drug use during pregnancy and risk of childhood cancer - is there an association? Cancer Epidemiol. 2015;39(1):73&#x2013;8.</Citation></Reference><Reference><Citation>Couto AC, Ferreira JD, Pombo-de-Oliveira MS, Koifman S. Pregnancy, maternal exposure to analgesic medicines, and leukemia in Brazilian children below 2 years of age. Eur J Cancer Prev. 2015;24(3):245&#x2013;52.</Citation></Reference><Reference><Citation>Gradel KO, Kaerlev L. Antibiotic use from conception to diagnosis of child leukaemia as compared to the background population: a nested case-control study. Pediatr Blood Cancer. 2015;62(7):1155&#x2013;61.</Citation></Reference><Reference><Citation>Ivy W 3rd, Nesheim SR, Paul SM, Ibrahim AR, Chan M, Niu X, et al. Cancer among children with perinatal exposure to HIV and antiretroviral medications-New Jersey, 1995&#x2013;2010. J Acquir Immune Defic Syndr. 2015;70(1):62&#x2013;6.</Citation></Reference><Reference><Citation>Momen NC, Olsen J, Gissler M, Kieler H, Haglund B, Li J. Exposure to systemic antibacterial medications during pregnancy and risk of childhood cancer. Pharmacoepidemiol Drug Saf. 2015;24(8):821&#x2013;9.</Citation></Reference><Reference><Citation>Hleyhel M, Goujon S, Delteil C, Vasiljevic A, Luzi S, Stephan JL, et al. Risk of cancer in children exposed to didanosine in utero. AIDS. 2016;30(8):1245&#x2013;56.</Citation></Reference><Reference><Citation>Mortensen JH, &#xd8;yen N, Fomina T, Melbye M, Tretli S, Vollset SE, et al. Supplemental folic acid in pregnancy and childhood cancer risk. Br J Cancer. 2016;114(1):71&#x2013;5.</Citation></Reference><Reference><Citation>Singer AW, Selvin S, Block G, Golden C, Carmichael SL, Metayer C. Maternal prenatal intake of one-carbon metabolism nutrients and risk of childhood leukemia. Cancer Causes Control. 2016;27(7):929&#x2013;40.</Citation></Reference><Reference><Citation>Vienneau D, Infanger D, Feychting M, Sch&#xfc;z J, Schmidt LS, Poulsen AH, et al. A multinational case-control study on childhood brain tumours, anthropogenic factors, birth characteristics and prenatal exposures: a validation of interview data. Cancer Epidemiol. 2016;40:52&#x2013;9.</Citation></Reference><Reference><Citation>Hargreave M, M&#xf8;rch LS, Andersen KK, Winther JF, Schmiegelow K, Kjaer SK. Maternal use of hormonal contraception and risk of childhood leukaemia: a nationwide, population-based cohort study. Lancet Oncol. 2018;19(10):1307&#x2013;14.</Citation></Reference><Reference><Citation>Momen NC, Munk-Olsen T, Li J, Ingstrup KG, Olsen J, Bergink V, et al. Antidepressant use during pregnancy and childhood cancer in the offspring. Pharmacoepidemiol Drug Saf. 2018;27(1):114&#x2013;8.</Citation></Reference><Reference><Citation>Ye X, Monchka BA, Righolt CH, Mahmud SM. Maternal use of antibiotics and cancer incidence risk in offspring: a population-based cohort study in Manitoba, Canada. Cancer Med. 2019;8(11):5367&#x2013;72.</Citation></Reference><Reference><Citation>Bauer H, Rios P, Schleiermacher G, Valteau-Couanet D, Bertozzi AI, Thebaud E, et al. Maternal and perinatal characteristics, congenital malformations and the risk of Wilms tumor: the ESTELLE study. Cancer Causes Control. 2020;31(5):491&#x2013;501.</Citation></Reference><Reference><Citation>Sepp&#xe4;l&#xe4; LK, Vettenranta K, Pitk&#xe4;niemi J, Hirvonen E, Leinonen MK, Madanat-Harjuoja LM. Maternal diabetes and risk of childhood cancer in the offspring. Int J Cancer. 2020;147(3):662&#x2013;8.</Citation></Reference><Reference><Citation>Hjorth S, Potteg&#xe5;rd A, Broe A, Hemmingsen CH, Leinonen MK, Hargreave M, et al. Prenatal exposure to nitrofurantoin and risk of childhood leukaemia: a registry-based cohort study in four Nordic countries. Int J Epidemiol. 2022;51(3):778&#x2013;88.</Citation></Reference><Reference><Citation>Vegrim HM, Dreier JW, Alvestad S, Gilhus NE, Gissler M, Igland J, et al. Cancer risk in children of mothers with epilepsy and high-dose folic acid use during pregnancy. JAMA Neurol. 2022;79(11):1130&#x2013;8.</Citation></Reference><Reference><Citation>Yan Y, Xie C, Di S, Wang Z, Wu M, Li Y, et al. Supplemental folic acid and/or multivitamins in pregnancy is associated with a decreased risk of childhood and adolescent nasopharyngeal carcinoma. J Dev Orig Health Dis. 2022;13(5):550&#x2013;5.</Citation></Reference><Reference><Citation>Avagyan M, Demirchyan A, Abrahamyan L. Risk factors of childhood cancer in Armenia: a case-control study. BMC Cancer. 2023;23(1):81.</Citation></Reference><Reference><Citation>Cheng S, McLaughlin JR, Brown MC, Al-Sawaihey H, Rutka J, Bouffet E, et al. Maternal and childhood medical history and the risk of childhood brain tumours: a case-control study in Ontario, Canada. Br J Cancer. 2023;129(2):318&#x2013;24.</Citation></Reference><Reference><Citation>Jung EM, Bunin GR, Ganguly A, Johnson RA, Spector LG. The association between maternal nutrient intake during pregnancy and the risk of sporadic unilateral retinoblastoma among offspring. Cancer Epidemiol. 2023;85:7.</Citation></Reference><Reference><Citation>Orimoloye HT, Deng C, Hansen J, Olsen J, Saechao C, Ritz B, et al. Hyperemesis gravidarum and the risk of childhood cancer - a case-control study in Denmark. Cancer Epidemiol. 2023;87:102472.</Citation></Reference><Reference><Citation>Qureshi N, Orimoloye H, Hansen J, Saechao C, Olsen J, Federman N, et al. Maternal anemia and childhood cancer: a population-based case-control study in Denmark. Cancer Epidemiol. 2023;82:102308.</Citation></Reference><Reference><Citation>Sirirungreung A, Hansen J, He D, Huang X, Ritz B, Heck JE. Exposure to nitrosatable drugs during pregnancy and childhood cancer: a matched case-control study in Denmark, 1996&#x2013;2016. Pharmacoepidemiol Drug Saf. 2023;32(4):496&#x2013;505.</Citation></Reference><Reference><Citation>Askins L, Orimoloye HT, Deng C, Hansen J, Olsen J, Ritz B, et al. Preeclampsia, antihypertensive medication use in pregnancy and risk of childhood cancer in offspring. Cancer Causes Control. 2024;35(1):43&#x2013;53.</Citation></Reference><Reference><Citation>Orimoloye HT, Hu YH, Federman N, Ritz B, Arah OA, Li CY, et al. Effects of hypertension and use of antihypertensive drugs in pregnancy on the risks of childhood cancers in Taiwan. Cancer Causes Control. 2024. https://doi.org/10.1007/s10552-024-01864-6.</Citation></Reference><Reference><Citation>Sirirungreung A, Lee PC, Hu YH, Liew Z, Ritz B, Heck JE. Maternal medically diagnosed infection and antibiotic prescription during pregnancy and risk of childhood cancer: a population-based cohort study in Taiwan, 2004 to 2015. Int J Cancer. 2024;154(4):626&#x2013;35.</Citation></Reference><Reference><Citation>Gudnadottir U, Fransson E, Ljungman G, Wikman A, Vlieghe E, Engstrand L, et al. Prenatal and early childhood exposure to proton pump inhibitors and antibiotics and the risk of childhood cancer: a nationwide population-based cohort study. Drug Saf. 2025;48(4):375&#x2013;88.</Citation></Reference><Reference><Citation>Brackmann LK, Mulanje L, L&#xfc;btow A, Marron M. New tool to assess quality of observational studies with their risk of bias (NOSROB) &#x2013; extension of the Newcastle Ottawa scale and the risk of bias in non-randomized studies. 2025. https://doi.org/10.17605/OSF.IO/HE3WA</Citation></Reference><Reference><Citation>Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. Systematic Reviews in Health Care. 2001. p. 285&#x2013;312.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557&#x2013;60.</Citation></Reference><Reference><Citation>Ziegler A, Lange S, Bender R. Systematische &#xdc;bersichten und Meta-Analysen. - Artikel Nr 19 der Statistik-Serie in der DMW -. 2004;129(S3):T11-T5. https://doi.org/10.1055/s-2004-836077.</Citation></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629&#x2013;34.</Citation></Reference><Reference><Citation>Harris RJ, Deeks JJ, Altman DG, Bradburn MJ, Harbord RM, Sterne JAC. Metan: fixed- and random-effects meta-analysis. Stata J. 2008;8(1):3&#x2013;28.</Citation></Reference><Reference><Citation>Metayer C, Milne E, Dockerty JD, Clavel J, Pombo-de-Oliveira MS, Wesseling C, et al. Maternal supplementation with folic acid and other vitamins and risk of leukemia in offspring: a childhood leukemia international consortium study. Epidemiology. 2014;25(6):811&#x2013;22.</Citation></Reference><Reference><Citation>Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robison LL. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children&#x2019;s Cancer Group. Cancer Causes Control. 1996;7(6):581&#x2013;90.</Citation></Reference><Reference><Citation>Greenop KR, Miller M, de Klerk NH, Scott RJ, Attia J, Ashton LJ, et al. Maternal dietary intake of folate and vitamins B6 and B12 during pregnancy and risk of childhood brain tumors. Nutr Cancer. 2014;66(5):800&#x2013;9.</Citation></Reference><Reference><Citation>Hargreave M, Jensen A, Hansen MK, Dehlendorff C, Winther JF, Schmiegelow K, et al. Association between fertility treatment and cancer risk in children. JAMA. 2019;322(22):2203&#x2013;10.</Citation></Reference><Reference><Citation>Hargreave M, M&#xf8;rch LS, Winther JF, Schmiegelow K, Kjaer SK. Association between maternal hormonal contraception use and central nervous system tumors in children. JAMA. 2022;327(1):59&#x2013;66.</Citation></Reference><Reference><Citation>Bailey HD, Rios P, Lacour B, Guerrini-Rousseau L, Bertozzi AI, Leblond P, et al. Factors related to pregnancy and birth and the risk of childhood brain tumours: The ESTELLE and ESCALE studies (SFCE, France). Int J Cancer. 2017;140(8):1757&#x2013;69.</Citation></Reference><Reference><Citation>Rios P, Bailey HD, Orsi L, Lacour B, Valteau-Couanet D, Levy D, et al. Risk of neuroblastoma, birth-related characteristics, congenital malformations and perinatal exposures: a pooled analysis of the ESCALE and ESTELLE French studies (SFCE). Int J Cancer. 2016;139(9):1936&#x2013;48.</Citation></Reference><Reference><Citation>Olshan AF, Smith J, Cook MN, Grufferman S, Pollock BH, Stram DO, et al. Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children&#x2019;s Cancer Group and the Pediatric Oncology Group. Am J Epidemiol. 1999;150(9):930&#x2013;8.</Citation></Reference><Reference><Citation>Preston-Martin S, Pogoda JM, Mueller BA, Holly EA, Lijinsky W, Davis RL. Maternal consumption of cured meats and vitamins in relation to pediatric brain tumors. Cancer Epidemiol Biomarkers Prev. 1996;5(8):599&#x2013;605.</Citation></Reference><Reference><Citation>Msallem E, Pacquement H, Olivier L, Brugi&#xe8;res L, Parker JL, Garnier N, et al. Association between perinatal factors and childhood lymphoma-a pooled analysis of the ESCALE and ESTELLE studies (SFCE). Pediatr Blood Cancer. 2025. https://doi.org/10.1002/pbc.31439.</Citation></Reference><Reference><Citation>Cocco P, Rapallo M, Targhetta R, Biddau PF, Fadda D. Analysis of risk factors in a cluster of childhood acute lymphoblastic leukemia. Arch Environ Health. 1996;51(3):242&#x2013;4.</Citation></Reference><Reference><Citation>Giuffr&#xe8; R, Liccardo G, Pastore FS, Spallone A, Vagnozzi R. Potential risk factors for brain tumors in children. An analysis of 200 cases. Childs Nerv Syst. 1990;6(1):8&#x2013;12.</Citation></Reference><Reference><Citation>Ognjanovic S, Blair C, Spector LG, Robison LL, Roesler M, Ross JA. Analgesic use during pregnancy and risk of infant leukaemia: a Children&#x2019;s Oncology Group study. Br J Cancer. 2011;104(3):532&#x2013;6.</Citation></Reference><Reference><Citation>Platamone CC, Deng C, Mazumder R, Ritz B, Olsen J, Hansen J, et al. Danish population based study of familial epilepsy and childhood cancer. Eur J Epidemiol. 2024;39(9):1005&#x2013;11.</Citation></Reference><Reference><Citation>Pacifici GM. Placental transfer of antibiotics administered to the mother: a review. Int J Clin Pharmacol Ther. 2006;44(2):57&#x2013;63.</Citation></Reference><Reference><Citation>Wiemels J. Perspectives on the causes of childhood leukemia. Chem Biol Interact. 2012;196(3):59&#x2013;67.</Citation></Reference><Reference><Citation>Nyangahu DD, Jaspan HB. Influence of maternal microbiota during pregnancy on infant immunity. Clin Exp Immunol. 2019;198(1):47&#x2013;56.</Citation></Reference><Reference><Citation>Stokholm J, Schj&#xf8;rring S, Eskildsen CE, Pedersen L, Bischoff AL, F&#xf8;lsgaard N, et al. Antibiotic use during pregnancy alters the commensal vaginal microbiota. Clin Microbiol Infect. 2014;20(7):629&#x2013;35.</Citation></Reference><Reference><Citation>Qu W, Liu L, Miao L. Exposure to antibiotics during pregnancy alters offspring outcomes. Expert Opin Drug Metab Toxicol. 2021;17(10):1165&#x2013;74.</Citation></Reference><Reference><Citation>Schilling AL, Rody A, Bossung V. Antibiotic use during pregnancy and childbirth: prospective observational study on prevalence, indications, and prescribing patterns in a German tertiary center. Geburtshilfe Frauenheilkd. 2023;83(2):192&#x2013;200.</Citation></Reference><Reference><Citation>Mulanje L, Brackmann LK, L&#xfc;btow A, Zeeb H, Ahrens W, Marron M, et al. Maternal Infections in Pregnancy and the Risk of Childhood Cancer&#x2013;a Systematic Review and Meta-Analysis. Pediatr Blood Cancer. 2024;71(S3):e31444.</Citation></Reference><Reference><Citation>Kelty E, Rae K, Jantzie LL, Wyrwoll CS, Preen DB. Prenatal opioid exposure and immune-related conditions in children. JAMA Netw Open. 2024;7(1):e2351933.</Citation></Reference><Reference><Citation>Miller NW, Seman BG, Akers SM, Povroznik JM, Brundage K, Fang W, et al. The impact of opioid exposure during pregnancy on the human neonatal immune profile. Pediatr Res. 2022;92(6):1566&#x2013;74.</Citation></Reference><Reference><Citation>Bremer L, Goletzke J, Wiessner C, Pagenkemper M, Gehbauer C, Becher H, et al. Paracetamol medication during pregnancy: insights on intake frequencies, dosages and effects on hematopoietic stem cell populations in cord blood from a longitudinal prospective pregnancy cohort. EBioMedicine. 2017;26:146&#x2013;51.</Citation></Reference><Reference><Citation>McParlin C, O&#x2019;Donnell A, Robson SC, Beyer F, Moloney E, Bryant A, et al. Treatments for hyperemesis Gravidarum and nausea and vomiting in pregnancy: a systematic review. JAMA. 2016;316(13):1392&#x2013;401.</Citation></Reference><Reference><Citation>Austin K, Wilson K, Saha S. Hyperemesis gravidarum. Nutr Clin Pract. 2019;34(2):226&#x2013;41.</Citation></Reference><Reference><Citation>Koren G, Ornoy A, Berkovitch M. Hyperemesis gravidarum-is it a cause of abnormal fetal brain development? Reprod Toxicol. 2018;79:84&#x2013;8.</Citation></Reference><Reference><Citation>French AE, Grant R, Weitzman S, Ray JG, Vermeulen MJ, Sung L, et al. Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther. 2003;74(3):288&#x2013;94.</Citation></Reference><Reference><Citation>Tobo&#x142;a-Wr&#xf3;bel K, Pietryga M, Dydowicz P, Napiera&#x142;a M, Br&#x105;zert J, Florek E. Association of oxidative stress on pregnancy. Oxid Med Cell Longev. 2020;2020:6398520.</Citation></Reference><Reference><Citation>Henderson BE, Ross R, Bernstein L. Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res. 1988;48(2):246&#x2013;53.</Citation></Reference><Reference><Citation>Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE. Increased cell division as a cause of human cancer. Cancer Res. 1990;50(23):7415&#x2013;21.</Citation></Reference><Reference><Citation>Improta-Brears T, Whorton AR, Codazzi F, York JD, Meyer T, McDonnell DP. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci U S A. 1999;96(8):4686&#x2013;91.</Citation></Reference><Reference><Citation>Zhou Y, Gu B, Brichant G, Singh JP, Yang H, Chang H, et al. The steroid hormone estriol (E3) regulates epigenetic programming of fetal mouse brain and reproductive tract. BMC Biol. 2022;20(1):93.</Citation></Reference><Reference><Citation>Rios P, Herlemont P, Fauque P, Lacour B, Jouannet P, Weill A, et al. Medically assisted reproduction and risk of cancer among offspring. JAMA Netw Open. 2024;7(5):e249429-e.</Citation></Reference><Reference><Citation>Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension. 2003;41(3):437&#x2013;45.</Citation></Reference><Reference><Citation>Eskenazi B, Fenster L, Sidney S, Elkin EP. Fetal growth retardation in infants of multiparous and nulliparous women with preeclampsia. Am J Obstet Gynecol. 1993;169(5):1112&#x2013;8.</Citation></Reference><Reference><Citation>Heck JE, Meyers TJ, Lombardi C, Park AS, Cockburn M, Reynolds P, et al. Case-control study of birth characteristics and the risk of hepatoblastoma. Cancer Epidemiol. 2013;37(4):390&#x2013;5.</Citation></Reference><Reference><Citation>Kennedy DO. B vitamins and the brain: mechanisms, dose and efficacy&#x2013;a review. Nutrients. 2016;8(2):68.</Citation></Reference><Reference><Citation>Hunsu VO, Facey COB, Fields JZ, Boman BM. Retinoids as chemo-preventive and molecular-targeted anti-cancer therapies. Int J Mol Sci. 2021. https://doi.org/10.3390/ijms22147731.</Citation></Reference><Reference><Citation>Mamede AC, Tavares SD, Abrantes AM, Trindade J, Maia JM, Botelho MF. The role of vitamins in cancer: a review. Nutr Cancer. 2011;63(4):479&#x2013;94.</Citation></Reference><Reference><Citation>Wilson RL, Gummow JA, McAninch D, Bianco-Miotto T, Roberts CT. Vitamin and mineral supplementation in pregnancy: evidence to practice. J Pharm Pract Res. 2018;48(2):186&#x2013;92.</Citation></Reference><Reference><Citation>Hovdenak N, Haram K. Influence of mineral and vitamin supplements on pregnancy outcome. Eur J Obstet Gynecol Reprod Biol. 2012;164(2):127&#x2013;32.</Citation></Reference><Reference><Citation>Peterson CT, Rodionov DA, Osterman AL, Peterson SN. B vitamins and their role in immune regulation and cancer. Nutrients. 2020;12(11):3380.</Citation></Reference><Reference><Citation>Revuelta JL, Buey RM, Ledesma-Amaro R, Vandamme EJ. Microbial biotechnology for the synthesis of (pro)vitamins, biopigments and antioxidants: challenges and opportunities. Microb Biotechnol. 2016;9(5):564&#x2013;7.</Citation></Reference><Reference><Citation>Fenech M. The role of folic acid and vitamin B12 in genomic stability of human cells. Mutat Res. 2001;475(1&#x2013;2):57&#x2013;67.</Citation></Reference><Reference><Citation>Vamvakas S, Vock EH, Lutz WK. On the role of DNA double-strand breaks in toxicity and carcinogenesis. Crit Rev Toxicol. 1997;27(2):155&#x2013;74.</Citation></Reference><Reference><Citation>Sharma JB, Sharma A, Bahadur A, Vimala N, Satyam A, Mittal S. Oxidative stress markers and antioxidant levels in normal pregnancy and pre-eclampsia. Int J Gynaecol Obstet. 2006;94(1):23&#x2013;7.</Citation></Reference><Reference><Citation>Powers HJ. Current knowledge concerning optimum nutritional status of riboflavin, niacin and pyridoxine. Proc Nutr Soc. 1999;58(2):435&#x2013;40.</Citation></Reference><Reference><Citation>Bennett LL, Rojas S, Seefeldt T. Role of antioxidants in the prevention of cancer. Journal of Experimental &amp; Clinical Medicine. 2012;4(4):215&#x2013;22.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">41267264</PMID><DateCompleted><Year>2025</Year><Month>11</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-7145</ISSN><JournalIssue CitedMedium="Internet"><Volume>222</Volume><Issue>Pt 1</Issue><PubDate><Year>2025</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Food research international (Ottawa, Ont.)</Title><ISOAbbreviation>Food Res Int</ISOAbbreviation></Journal><ArticleTitle>Disruption of the gut microbiota induces the LCA/TRPV6 signalling axis, impairing desmosome junctions in vitamin A-deficient rats.</ArticleTitle><Pagination><StartPage>117656</StartPage><MedlinePgn>117656</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.foodres.2025.117656</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0963-9969(25)01994-5</ELocationID><Abstract><AbstractText>Maternal vitamin A deficiency (VAD) is a widespread public health issue, particularly in low- and middle-income countries, and is associated with microbial dysbiosis and impaired intestinal health in offspring. However, the effects of VAD-induced changes in microbiota-derived metabolites on gut barrier integrity and the underlying mechanisms remain poorly understood. To address this, the present study investigated how maternal VAD affects colonic barrier integrity in offspring via secondary bile acids and assessed whether administration of postnatal vitamin A supplementation (VAS) can restore intestinal function. Compared with the vitamin A normal (VAN) group, maternal VAD disturbed the gut microbiota composition, elevated lithocholic acid (LCA) levels (&#x223c; 4.2-fold, p&#xa0;&lt;&#xa0;0.0001), and impaired colonic epithelial barrier integrity in offspring. Furthermore, maternal VAD significantly increased the mRNA (&#x223c;2.8-fold, p&#xa0;=&#xa0;0.0028) and protein (&#x223c;1.6-fold, p&#xa0;=&#xa0;0.0011) expression levels of transient receptor potential cation channel subfamily V member 6 (TRPV6). Using in vitro Caco-2 cell models, we demonstrated that LCA upregulated TRPV6 expression through vitamin D receptor/retinoid X receptor &#x3b1; (VDR/RXR&#x3b1;), which leads to monolayer epithelial barrier impairment. Importantly, postnatal VAS effectively restored the gut microbiota balance, inhibited the LCA/TRPV6 signalling axis, and restored colonic epithelial barrier function in offspring. Overall, this study elucidates, for the first time, the critical role of the LCA/TRPV6 signalling axis in mediating offspring colonic epithelial barrier dysfunction induced by maternal VAD. Moreover, our findings highlight the therapeutic potential of early postnatal VAS for mitigating gastrointestinal disorders in offspring resulting from maternal vitamin A malnutrition during pregnancy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Junyan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Growth, Development and Mental Health Center of Children and Adolescents, Children's Hospital of Chongqing Medical University, Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yushuang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Growth, Development and Mental Health Center of Children and Adolescents, Children's Hospital of Chongqing Medical University, Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Bei</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Growth, Development and Mental Health Center of Children and Adolescents, Children's Hospital of Chongqing Medical University, Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Binlin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Growth, Development and Mental Health Center of Children and Adolescents, Children's Hospital of Chongqing Medical University, Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Growth, Development and Mental Health Center of Children and Adolescents, Children's Hospital of Chongqing Medical University, Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Growth, Development and Mental Health Center of Children and Adolescents, Children's Hospital of Chongqing Medical University, Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Zhujun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Growth, Development and Mental Health Center of Children and Adolescents, Children's Hospital of Chongqing Medical University, Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yuting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Children's Hospital of Chongqing Medical University, China. Electronic address: charry_5678@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Growth, Development and Mental Health Center of Children and Adolescents, Children's Hospital of Chongqing Medical University, Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, Chongqing, China. Electronic address: jchen010@hospital.cqmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Food Res Int</MedlineTA><NlmUniqueID>9210143</NlmUniqueID><ISSNLinking>0963-9969</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>5QU0I8393U</RegistryNumber><NameOfSubstance UI="D008095">Lithocholic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>11103-57-4</RegistryNumber><NameOfSubstance UI="D014801">Vitamin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050916">TRPV Cation Channels</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018167">Receptors, Calcitriol</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C120776">TRPV6 channel</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015220">Calcium Channels</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014802" MajorTopicYN="Y">Vitamin A Deficiency</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008095" MajorTopicYN="Y">Lithocholic Acid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018938" MajorTopicYN="N">Caco-2 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014801" MajorTopicYN="N">Vitamin A</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050916" MajorTopicYN="Y">TRPV Cation Channels</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018167" MajorTopicYN="N">Receptors, Calcitriol</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015220" MajorTopicYN="Y">Calcium Channels</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007413" MajorTopicYN="N">Intestinal Mucosa</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="N">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003106" MajorTopicYN="N">Colon</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Gut microbiota</Keyword><Keyword MajorTopicYN="N">Gut mucosal barrier</Keyword><Keyword MajorTopicYN="N">Lithocholic acid (LCA)</Keyword><Keyword MajorTopicYN="N">TRPV6</Keyword><Keyword MajorTopicYN="N">VDR/RXR&#x3b1;</Keyword><Keyword MajorTopicYN="N">Vitamin a deficiency (VAD)</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>21</Day><Hour>1</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41267264</ArticleId><ArticleId IdType="doi">10.1016/j.foodres.2025.117656</ArticleId><ArticleId IdType="pii">S0963-9969(25)01994-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>